(Q34316400)

English

What's fueling the biotech engine-2011 to 2012.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

What's fueling the biotech engine-2011 to 2012. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Saurabh Rob Aggarwal

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Nature Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1191-1197

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2437

21 January 2018

U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2437

21 January 2018

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2437

21 January 2018

The Past 200 Years in Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2437

21 January 2018

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2437

21 January 2018

Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab in the treatment of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted cancer therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Maintenance Rituximab Now Ready for PRIMA-Time?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What's fueling the biotech engine-2009-2010

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What's fueling the biotech engine--2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What's fueling the biotech engine--2010 to 2011

1 reference

https://pubmed.ncbi.nlm.nih.gov/23222785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NBT.2437

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34316400&oldid=2196497259"